País: Israel
Língua: hebraico
Origem: Ministry of Health
IMIGLUCERASE 200 U/VIAL
SANOFI - AVENTIS ISRAEL LTD
A16AB02
POWDER FOR SOLUTION FOR INFUSION
I.V
GENZYME CORPORATION, USA
IMIGLUCERASE
For the long term enzyme replacement therapy for patients with a confirmed diagnosis of Type 1 gaucher disease that results in one or more of the following conditions: - Anemia , - Thrombocytopenia , - Bone disease , - Hepatomegaly or splenomegaly.
2010-08-01